Volume 15, Number 3—March 2009
Dispatch
Human Bocavirus and KI/WU Polyomaviruses in Pediatric Intensive Care Patients
Table 2
Patient no. | Diagnosis | Virus (Ct value) | Sample type | Sex | Age, mo | Immunocompromised | Other underlying disease | Length of stay, d | Other viruses |
---|---|---|---|---|---|---|---|---|---|
LRTI group | |||||||||
1 | LRTI | HBoV (39.4) | NPA | F | 13 | No | Pulmonary dysplasia (home mechanical ventilation) | 10 | Adeno, hMPV |
2 | LRTI | HBoV (15.0) | NPA | F | 9 | No | IRDS, PVL | 10 | Adeno |
3 | LRTI | HBoV (16.6) | NPA | M | 13 | No | Recurrent wheezing | 5 | RSV |
4 | LRTI | HBoV (15.0) | NPA | F | 19 | No | IRDS | 7 | None |
5 | LRTI | WUPyV (19.6) | NPA | M | 1 | No | None | 11 | RSV |
6 |
LRTI |
WUPyV (34.1) |
NPA |
F |
41 |
No |
Mitochondrial encephalopathy |
18 |
Influenza |
Control group | |||||||||
7 | Sepsis | HBoV (36.5) | NPA | F | 27 | No | None | 7 | NA |
8 | Infectious meningitis | HBoV (34.7) | NPA | F | 100 | No | 22Q11 deletion (cardiac and neurologic disease) | 3 | NA |
9 | URTI | HBoV (37.9) | NPA | M | 41 | No | Spinal muscular atrophy | 74 | NA |
10 | Observation after brain biopsy | HBoV/ KIPyV (32/39) | NPA | F | 127 | Yes | AML, BMT, Brochiolitis obliterans | 46 | NA |
11 | VSD closure | WUPyV (33.8) | Throat swab | F | 15 | No | VSD | 2 | NA |
12 | Septic shock | WUPyV (34.4) | NPA | M | 40 | No | None | 19 | NA |
13 | Cardiac malformation | KIPyV (34.1) | NPA | F | 4 | No | Cardiac malformation | 14 | NA |
14 | Septic shock | KIPyV (23.1) | NPA | M | 152 | Yes | AML, aplasia | 11 | NA |
15 | ALTE | KIPyV (26.7) | NPA | M | 2 | No | None | 8 | NA |
*PICU, Pediatric Intensive Care Unit, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands; LRTI, lower respiratory tract infection; HBoV, human bocavirus; KIPyV, KI polyomavirus; WUPyV, WU polyomavirus; Ct, cycle threshold; NPA, nasopharyngeal aspirate; Adeno, adenovirus; hMPV, human metapneumovirus; RSV, respiratory syncytial virus; IRDS, idiopathic respiratory distress syndrome; PVL, periventricular leukomalacia; NA, not assessed; URTI, upper respiratory tract infection; AML, acute myeloid leukemia; BMT, bone marrow transplant; VSD, ventricular septal defect; ALTE, apparent life-threatening event.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.